THE FIRST US STUDY TO ASSESS THE FEASIBILITY AND SAFETY OF ENDOCARDIAL DELIVERY OF ALLOGENIC MESENCHYMAL PRECURSOR CELLS IN PATIENT WITH HEART FAILURE: THREE-MONTH INTERIM ANALYSIS

Journal article

Peer reviewed

Nabil Dib, Tim Henry, Anthony De Maria, Silviu Itescu, Megan McCarthy, Susan Jaggar, Nicole Taylor, Ann Campbell, Henry Krum, Kendra Bartels, …

Journal of the American College of Cardiology, Vol.55(10), pp.A216.E2048-A216.E2048

03/09/2010

Abstract

Cardiology

1 Record Views

Title: THE FIRST US STUDY TO ASSESS THE FEASIBILITY AND SAFETY OF ENDOCARDIAL DELIVERY OF ALLOGENIC MESENCHYMAL PRECURSOR CELLS IN PATIENT WITH HEART FAILURE: THREE-MONTH INTERIM ANALYSIS
Creators: Nabil Dib
Tim Henry
Anthony De Maria
Silviu Itescu
Megan McCarthy
Susan Jaggar
Nicole Taylor
Ann Campbell
Henry Krum
Kendra Bartels
Donna Skerrett
Emerson Perin
Publication Details: Journal of the American College of Cardiology, Vol.55(10), pp.A216.E2048-A216.E2048
Publisher: Elsevier Limited
Identifiers: 991006261164902656
Academic Unit: Cardiology
Language: English
Resource Type: Journal article